SCHEMBL20154173

SCHEMBL20154173

Cc1nnnn1C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
P2RX4 Q99571 3/20 0.47
P2RX1 P51575 1/20 0.47
P2RX3 P56373 1/20 0.47
HTR2C P28335 1/20 0.45
LMNA P02545 1/20 0.44
DAGLA Q9Y4D2 2/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
MAPK1 P28482 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6579876 0.82 P2RX4 (0.47) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL24704613 0.82 ATM (0.46) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL20154211 0.79 ALDH1A1 (0.47) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL5662395 0.78 DAGLA (0.49) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL20154212 0.76 TDP1 (0.50) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL21187189 0.75 P2RX4 (0.43) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL9880597 0.75 ALDH1A1 (0.49) ALDH1A1P2RX4P2RX1P2RX3HTR2C
SCHEMBL22825569 0.73 L3MBTL1 (0.57) ALDH1A1LMNASMN1; SMN2L3MBTL1TDP1
SCHEMBL2495018 0.73 GAA (0.55) P2RX4P2RX1P2RX3LMNAKMT2A
SCHEMBL20419496 0.73 ALDH1A1 (0.47) ALDH1A1P2RX4P2RX1P2RX3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538512-B1 NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2021-06-16 EP disclosed
WO-2021018839-A1 ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS BAYER ANIMAL HEALTH GMBH (DE) 2021-02-04 WO disclosed
WO-2019002132-A1 NEW AZAQUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-01-03 WO disclosed
WO-2018087036-A1 NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2018-05-17 WO disclosed